The largest database of trusted experimental protocols

35 protocols using hindiii

1

Generating Neuritin siRNA Plasmids

Check if the same lab product or an alternative is used in the 5 most similar protocols
A neuritin siRNA plasmid was generated by using the pBS/U6 vector (Wan et al., 2005 (link)). Briefly, a 22 nucleotide (nt) oligo (oligo 1) at nt 333–351, 406–424 or 456–474 of the human neuritin coding region was first inserted into the pBS/U6 vector after digesting the vector with ApaI (Promega) and HindIII (Promega). The inverted motif containing a 6-nt spacer and five thymidines (oligo 2) was then subcloned between the Hind III and EcoR I (Promega) sites of the intermediate plasmid to generate pBS/U6-Neuritin-siRNA-1, -2 and -3. siRNA plasmids were transfected into cells as described below, and the efficiency of knockdown was verified by western blotting.
+ Open protocol
+ Expand
2

Extraction and Amplification of Genetic Material

Check if the same lab product or an alternative is used in the 5 most similar protocols
TRIzol reagent was purchased from Invitrogen Life Technologies (Carlsbad, CA, USA), and the one-step RT-PCR kit and Qiagen plasmid mini kit were purchased from Qiagen (Hilden, Germany). BamHI and HindIII were produced by Promega Corp. (Madison, WI, USA), 5-fluorouracil (5-FU) was produced in the Hubei Yuancheng Pharmaceutical Co., Ltd. (Wuhan, China) and recombinant human growth hormone (rhGH) was produced by Merck Serono [(Schweiz) AG (Zug, Switzerland)].
+ Open protocol
+ Expand
3

Plasmid DNA Digestion and Probe Labeling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Purified plasmid DNA was digested overnight at 37 °C with restriction enzymes HindIII and PvuII (Promega, Fitchburg, WI, USA). Probe-labelling was performed using DIG RNA Labelling kit (SP6/T7) as recommended by the manufacturer (Roche Diagnostics, Oslo, Norway) to generate DIG-labelled RNA anti-sense and sense probes, respectively. Labelled RNA was purified using illustra™ probe Quant™ G-50 μ columns probe purification kit (GE Healthcare, Oslo, Norway) according to the manufacturer’s instructions.
+ Open protocol
+ Expand
4

Validation of PCR Assay for Ehrlichia Spp.

Check if the same lab product or an alternative is used in the 5 most similar protocols
As positive controls we used the five major Ehrlichia spp., mainly E. ruminantium, E. canis, E. chaffeensis, E. ewingii and E. muris. We also tested Ehrlichia that were available to us and have been previously reported to occur in ruminants, mainly E. ovina [4 (link)], Ehrlichia sp. BOV2010 [13 (link)] and the Panola Mountain Ehrlichia [9 (link)]. We used DNA extracted in previous studies from E. ruminantium [10 (link)] and E. canis [20 (link)], DNA extracted as described below from tissue cultures of E. canis (Oklahoma) and E. chaffeensis (Arkansas) (supplied by Gregory Dasch, Centers for Disease Control, Atlanta), from blood stabilates (E. ovina and Ehrlichia sp. BOV2010), and from an Amblyomma variegatum positive for the Panola Mountain Ehrlichia by PCR (unpublished data). We also used plasmids that were created to contain an appropriate portion of the 16S rRNA gene of E. ewingii and E. muris using the pIDTSMART cloning vector (Integrated DNA Technologies, Coralville, IA, USA) and linearization with HindIII (Promega, Madison, WI, USA).
To test the specificity of our PCR, we tested DNAs extracted from blood of cattle verified to be infected with A. marginale (identical nucleotide 16S rRNA sequences with CP006847) and A. phagocytophilum (identical 16S rRNA sequences with KJ782389).
+ Open protocol
+ Expand
5

C4 Promoter Deletion Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The C4 promoter region was PCR amplified from human genomic DNA via full length-forward and reverse primers (Table 1). Then, the PCR product was cloned into pGEM-T-Easy vector (Promega, Madison, WI, United States). A single clone of C4 promoter was identified and digested by XhoI and HindIII (Promega). The C4 promoter was then subcloned into reporter gene vector pGL4.19 basic (Promega) at the XhoI and HindIII restriction sites to generate pC4-1,007/+44. To generate the 5’-deletion constructs, pC4-119/+44, pC4-102/+44, pC4-92/+44, pC4-72/+44, and pC4-48/+44, genomic DNA fragments were PCR amplified from the pGL4.19 plasmid using forward (segment 1 to segment 5) and reverse primers (Table 1). Then, the PCR product was digested by HindIII and XhoI, and subcloned into pGL4.19 basic.
+ Open protocol
+ Expand
6

Bacteriophage DNA Restriction Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Genomic DNA (1 μg/μL) of each bacteriophage was digested individually with EcoRI, HaeIII, HindIII, and SalI restriction enzymes (Promega, United States) according to the manufacturer’s protocols and incubated at 37°C for 1 h. The digested product was electrophoresed and visualized as mentioned in the above section.
+ Open protocol
+ Expand
7

NF-κB p65 Overexpression in HEL Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The expression plasmid NF-kB p65-pCMV4 was obtained from Addgene (plasmid 21966; pCMV4 p65) (17 (link)). The 2.5 kb p65 cDNA was released with Hind III (Promega) and the recircled empty pCMV4 vector DNA was used as control. HEL cells were transiently cotransfected using Lipofectamine 2000 (Invitrogen) with 1.6 μg of p65 expression plasmid p65-pCMV4 or empty pCMV4 vector and PLCβ2 promoter luciferase reporter constructs (wildtype or with 13 bp deletion). The cells were harvested 24 h for luciferase activity and immunoblotting.
+ Open protocol
+ Expand
8

Recombinant BLVp24 Protein Purification

Check if the same lab product or an alternative is used in the 5 most similar protocols
The pGEM-BLVp24 vector was digested with BamHI and HindIII (Promega, USA) restriction enzymes and analyzed by low melting point agar gel electrophoresis. The DNA fragment corresponding to the complete sequence that codifies de p24 capsid protein was cut out of the gel, purified (Wizard SV Gel, Promega, USA) and cloned into the pET-20 vector previously digested with the same restriction enzymes. The resulting plasmid (pET-20-BLVp24) was transformed into competent ER2566 E. coli (New England Biolabs, USA) for expression as a fusion protein containing histidine, a maltose binding protein (MBP) and a restriction site for the tobacco etch virus (TEV) protease at the N-terminus. The expression of the recombinant His-Mbp-TEV-BLVp24 (BLVp24r) was induced overnight with 0.1 M isopropyl-β-D-thiogalactopyranoside (IPTG, Sigma, USA). The bacteria cells were pelleted (4000 × g, 30 min, 4 °C), suspended in lysis buffer (20 mM NaH2PO4, 500 mM NaCl, 10 mM Imidazol, pH 8.0) and sonicated thrice (70 watts) (Ultronic, Brazil). Then, the sonicated bacteria was centrifuged (13,000 × g, 1 h, 4 °C) and the supernatant filtered (0.22 μM) and purified using the Äkta Pure Chromatography System (GE Healthcare, Germany) connected to a HisTrap (GE Healthcare, Germany) column. The purified proteins were quantified, aliquoted and stored at −80° until use.
+ Open protocol
+ Expand
9

Cloning and Expression of Cementoin-SLPI Fusion Protein

Check if the same lab product or an alternative is used in the 5 most similar protocols
As it was previously described for SLPI32 (link) cementoin mRNA was extracted from HeLa cells (epitheloid cervix carcinoma) and reverse-transcribed to cDNA using oligo-dT primers with MMLV-RT (Promega, Madison, WI) according to specifications of the manufacturer. Two pairs of modified PCR primers (forward primer GTTCTACATATGGCTGTCACGGGAGTT and reverse primer TTAAAGGTCAAGATAAAGTCAAAAAGCTT) were used to generate the complete open reading frame of the cementoin peptide from the obtained cDNA. The SLPI and cementoin cloned genes were amplified by PCR with modified primers, these primers created new recognition sites for restriction enzyme and an ATG (Met) translation initiation codon on the 5′ end. The plasmids, pGEMT-SLPI and PGEMT-cementoin were digested with the restriction enzimes ApaI and HindIII (Promega, Madison, WI) and cementoin and SLPI fragments were incubated together in equimolar amounts in a ligation reaction with the enzyme T4 DNA ligase (Promega). This insert was then ligated to the pET22b+expression vector (Stratagen).
The pET-Cementoin-SLPI vector was purified and electroporated in the E. coli expression strain Origami (Novagen, Inc., an Affiliate of Merck KGaA, Darmstadt, Germany). Origami host strains have mutations in both the thioredoxin reductase (trxB) and glutathione reductase (gor) genes, which greatly enhance disulfide bond formation in the cytoplasm.
+ Open protocol
+ Expand
10

Cloning and Expression of M2e-NP Fusion Protein

Check if the same lab product or an alternative is used in the 5 most similar protocols
The M2e-NP fusion gene (1617 bp) was cloned into yT&A cloning vector (Yeastern Biotech, Taipei, Taiwan) and multiplied in E. coli strain TOP 10. The yT&A-M2e-NP plasmid and pRSET B vector were digested with BamHI (Promega, USA) and HindIII (Promega, USA). The digested products were ligated at 1:3 molar ratio (pRSET B: M2e-NP) using T4 DNA ligase (Fisher Scientific, USA). The ligation mixture (5 μL) was added into 100 μL of E. coli strain Top 10, and then incubated at 45 °C for 90 s. About 100 μL of Luria Bertani (LB) broth (Thermofisher, Waltham, MA, USA) was added into the mixture, and incubated at 37 °C on a shaker for 45 min. On LB bacterial agar (Thermofisher, USA), 100 μL of culture was plated using a spreader. The plate was incubated overnight at 37 °C. Bacterial colonies were selected randomly and screened by using PCR. pRSET B-M2e-NP (Figure 1) was isolated and sequenced to confirm the presence of M2e-NP fusion gene and its nucleotide sequence.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!